Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Determination of the Transplacental Transfer of Paclitaxel and Antipyrine by High Performance Liquid Chromatography Coupled with Photodiode Array Detector.

Ali S, Albekairi N, Wang XM, Patrikeeva S, Nanovskaya TN, Ahmed MS, Rytting E.

J Liq Chromatogr Relat Technol. 2018;41(5):232-238. doi: 10.1080/10826076.2018.1436068. Epub 2018 Feb 26.

2.

Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling.

Tian B, Hosoki K, Liu Z, Yang J, Zhao Y, Sun H, Zhou J, Rytting E, Kaphalia L, Calhoun WJ, Sur S, Brasier AR.

J Allergy Clin Immunol. 2019 Apr;143(4):1380-1394.e9. doi: 10.1016/j.jaci.2018.09.029. Epub 2018 Oct 13.

PMID:
30321559
3.

Effect of CYP2C9 Polymorphisms on the Pharmacokinetics of Indomethacin During Pregnancy.

Shah M, Xu M, Shah P, Wang X, Clark SM, Costantine M, West HA, Nanovskaya TN, Ahmed MS, Abdel-Rahman SZ, Venkataramanan R, Caritis SN, Hankins GDV, Rytting E.

Eur J Drug Metab Pharmacokinet. 2019 Feb;44(1):83-89. doi: 10.1007/s13318-018-0505-7.

PMID:
30159654
4.

Efficacy of Novel Highly Specific Bromodomain-Containing Protein 4 Inhibitors in Innate Inflammation-Driven Airway Remodeling.

Tian B, Liu Z, Litvinov J, Maroto R, Jamaluddin M, Rytting E, Patrikeev I, Ochoa L, Vargas G, Motamedi M, Ameredes BT, Zhou J, Brasier AR.

Am J Respir Cell Mol Biol. 2019 Jan;60(1):68-83. doi: 10.1165/rcmb.2017-0445OC.

PMID:
30153047
5.

Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models.

Sampson CM, Kasper JM, Felsing DE, Raval SR, Ye N, Wang P, Patrikeev I, Rytting E, Zhou J, Allen JA, Hommel JD.

Pharmacol Res Perspect. 2018 Aug 23;6(5):e00425. doi: 10.1002/prp2.425. eCollection 2018 Oct.

6.

HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media.

Shah M, Bourner L, Ali S, Al-Enazy S, Youssef MM, Fisler M, Rytting E.

Separations. 2018 Mar;5(1). pii: 9. doi: 10.3390/separations5010009. Epub 2018 Jan 24.

7.

Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation.

Tian B, Liu Z, Yang J, Sun H, Zhao Y, Wakamiya M, Chen H, Rytting E, Zhou J, Brasier AR.

Cell Rep. 2018 Apr 24;23(4):1138-1151. doi: 10.1016/j.celrep.2018.03.106.

8.

Cytotoxicity of Endocytosis and Efflux Inhibitors in the BeWo Cell Line.

Shah M, Bourner L, Ali S, Al-Enazy S, Rytting E.

J Pharm Res Int. 2017;17(5). pii: JPRI.34606. doi: 10.9734/JPRI/2017/34606. Epub 2017 Jul 1.

9.

Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.

Fokina VM, Xu M, Rytting E, Abdel-Rahman SZ, West H, Oncken C, Clark SM, Ahmed MS, Hankins GD, Nanovskaya TN.

Drug Metab Dispos. 2016 Nov;44(11):1832-1838. Epub 2016 Aug 15.

10.

Placental control of drug delivery.

Al-Enazy S, Ali S, Albekairi N, El-Tawil M, Rytting E.

Adv Drug Deliv Rev. 2017 Jul 1;116:63-72. doi: 10.1016/j.addr.2016.08.002. Epub 2016 Aug 12. Review.

11.

Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, Zamudio S, Illsley NP, Myatt L, Colvis C, Costantine MM, Haas DM, Sadovsky Y, Weiner C, Rytting E, Bidwell G.

Am J Obstet Gynecol. 2016 Jul;215(1 Suppl):S1-S46. doi: 10.1016/j.ajog.2016.03.001. Epub 2016 Mar 10.

12.

Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast.

Albekairi NA, Al-Enazy S, Ali S, Rytting E.

Ther Deliv. 2015;6(12):1325-34. doi: 10.4155/tde.15.79.

13.

Pharmacokinetics of metoprolol during pregnancy and lactation.

Ryu RJ, Eyal S, Easterling TR, Caritis SN, Venkataraman R, Hankins G, Rytting E, Thummel K, Kelly EJ, Risler L, Phillips B, Honaker MT, Shen DD, Hebert MF.

J Clin Pharmacol. 2016 May;56(5):581-9. doi: 10.1002/jcph.631. Epub 2015 Dec 4.

14.

Exploring the interactions of nanoparticles with multiple models of the maternal--fetal interface.

Rytting E.

Nanotoxicology. 2015 May;9 Suppl 1:137-8. doi: 10.3109/17435390.2013.877997. No abstract available.

PMID:
25923351
15.

Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.

Lopalco A, Ali H, Denora N, Rytting E.

Int J Nanomedicine. 2015 Mar 11;10:1985-96. doi: 10.2147/IJN.S77498. eCollection 2015.

16.

Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus).

Rytting E, Wang X, Vernikovskaya DI, Zhan Y, Bauer C, Abdel-Rahman SM, Ahmed MS, Nanovskaya TN.

Drug Metab Dispos. 2014 Oct;42(10):1773-9. doi: 10.1124/dmd.114.058255. Epub 2014 Aug 5.

17.

Influences of nanomaterials on the barrier function of epithelial cells.

Ali S, Rytting E.

Adv Exp Med Biol. 2014;811:45-54. doi: 10.1007/978-94-017-8739-0_3. Review.

PMID:
24683026
18.

Modelling of human transplacental transport as performed in Copenhagen, Denmark.

Mathiesen L, Mørck TA, Zuri G, Andersen MH, Pehrson C, Frederiksen M, Mose T, Rytting E, Poulsen MS, Nielsen JK, Knudsen LE.

Basic Clin Pharmacol Toxicol. 2014 Jul;115(1):93-100. doi: 10.1111/bcpt.12228. Epub 2014 Apr 18. Review.

19.

Pharmacokinetics of indomethacin in pregnancy.

Rytting E, Nanovskaya TN, Wang X, Vernikovskaya DI, Clark SM, Cochran M, Abdel-Rahman SM, Venkataramanan R, Caritis SN, Hankins GD, Ahmed MS.

Clin Pharmacokinet. 2014 Jun;53(6):545-51. doi: 10.1007/s40262-014-0133-6.

20.

Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.

Ali H, Kalashnikova I, White MA, Sherman M, Rytting E.

Int J Pharm. 2013 Sep 15;454(1):149-57. doi: 10.1016/j.ijpharm.2013.07.010. Epub 2013 Jul 12.

21.

Kinetics of silica nanoparticles in the human placenta.

Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E.

Nanotoxicology. 2015 May;9 Suppl 1:79-86. doi: 10.3109/17435390.2013.812259. Epub 2013 Jul 1.

22.

A liquid chromatography method with single quadrupole mass spectrometry for quantitative determination of indomethacin in maternal plasma and urine of pregnant patients.

Wang X, Vernikovskaya DI, Nanovskaya TN, Rytting E, Hankins GD, Ahmed MS.

J Pharm Biomed Anal. 2013 May 5;78-79:123-8. doi: 10.1016/j.jpba.2013.02.006. Epub 2013 Feb 15.

23.

Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry.

Wang X, Rytting E, Abdelrahman DR, Nanovskaya TN, Hankins GD, Ahmed MS.

Biomed Chromatogr. 2013 Jul;27(7):866-73. doi: 10.1002/bmc.2873. Epub 2013 Feb 12.

24.

Nanomedicine for uterine leiomyoma therapy.

Ali H, Kilic G, Vincent K, Motamedi M, Rytting E.

Ther Deliv. 2013 Feb;4(2):161-75. doi: 10.4155/tde.12.144.

25.

In vitro placental model optimization for nanoparticle transport studies.

Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, Rytting E.

Int J Nanomedicine. 2012;7:497-510. doi: 10.2147/IJN.S26601. Epub 2012 Jan 31.

26.

Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "ouzo region" upon drug loading.

Beck-Broichsitter M, Rytting E, Lebhardt T, Wang X, Kissel T.

Eur J Pharm Sci. 2010 Oct 9;41(2):244-53. doi: 10.1016/j.ejps.2010.06.007. Epub 2010 Jun 22.

PMID:
20600881
27.

Influence of particle size and material properties on mucociliary clearance from the airways.

Henning A, Schneider M, Nafee N, Muijs L, Rytting E, Wang X, Kissel T, Grafahrend D, Klee D, Lehr CM.

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):233-41. doi: 10.1089/jamp.2009.0806. Review.

PMID:
20500091
28.

Placental transport and in vitro effects of Bisphenol A.

Mørck TJ, Sorda G, Bechi N, Rasmussen BS, Nielsen JB, Ietta F, Rytting E, Mathiesen L, Paulesu L, Knudsen LE.

Reprod Toxicol. 2010 Aug;30(1):131-7. doi: 10.1016/j.reprotox.2010.02.007. Epub 2010 Mar 7.

PMID:
20214975
29.

In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles.

Rytting E, Bur M, Cartier R, Bouyssou T, Wang X, Krüger M, Lehr CM, Kissel T.

J Control Release. 2010 Jan 4;141(1):101-7. doi: 10.1016/j.jconrel.2009.08.021. Epub 2009 Aug 29.

PMID:
19720096
30.

Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion.

Poulsen MS, Rytting E, Mose T, Knudsen LE.

Toxicol In Vitro. 2009 Oct;23(7):1380-6. doi: 10.1016/j.tiv.2009.07.028. Epub 2009 Jul 30.

PMID:
19647068
31.

Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium.

Mathiesen L, Rytting E, Mose T, Knudsen LE.

Basic Clin Pharmacol Toxicol. 2009 Sep;105(3):181-7. doi: 10.1111/j.1742-7843.2009.00431.x. Epub 2009 Jun 5.

32.

Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA.

Cai C, Mao S, Germershaus O, Schaper A, Rytting E, Chen D, Kissel T.

J Microencapsul. 2009 Jun;26(4):334-45. doi: 10.1080/02652040802354707. Epub 2008 Oct 20.

PMID:
18720198
33.

Biodegradable polymeric nanocarriers for pulmonary drug delivery.

Rytting E, Nguyen J, Wang X, Kissel T.

Expert Opin Drug Deliv. 2008 Jun;5(6):629-39. doi: 10.1517/17425247.5.6.629 . Review.

PMID:
18532919
34.

Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.

Cai C, Bakowsky U, Rytting E, Schaper AK, Kissel T.

Eur J Pharm Biopharm. 2008 May;69(1):31-42. Epub 2007 Oct 12.

PMID:
18023160
35.

Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells.

Rytting E, Audus KL.

Biochem Pharmacol. 2008 Feb 1;75(3):745-51. Epub 2007 Sep 19.

36.

Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells.

Rytting E, Audus KL.

J Pharm Pharmacol. 2007 Aug;59(8):1095-102.

PMID:
17725851
37.

Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Rytting E, Bryan J, Southard M, Audus KL.

Biochem Pharmacol. 2007 Mar 15;73(6):891-900. Epub 2006 Dec 1.

38.

In vitro models for studying trophoblast transcellular transport.

Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL.

Methods Mol Med. 2006;122:225-39.

39.

Aqueous and cosolvent solubility data for drug-like organic compounds.

Rytting E, Lentz KA, Chen XQ, Qian F, Vakatesh S.

AAPS J. 2005 Apr 26;7(1):E78-105.

40.

Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells.

Rytting E, Audus KL.

J Pharmacol Exp Ther. 2005 Jan;312(1):192-8. Epub 2004 Aug 17.

PMID:
15316089
41.

A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems.

Rytting E, Lentz KA, Chen XQ, Qian F, Venkatesh S.

Pharm Res. 2004 Feb;21(2):237-44.

PMID:
15032304

Supplemental Content

Loading ...
Support Center